Vancocin vancomycin news

In a federal lawsuit, the U.S. Federal Trade Commission alleged that the Shire ViroPharma Inc. subsidiary of Shire abused the Citizen's Petition process and violated antitrust laws to delay generic competition for antibiotic Vancocin vancomycin.

The FTC alleged that ViroPharma submitted "repetitive, serial and meritless filings" to FDA to delay the agency's approval of generic versions of the drug. The agency filed the suit in the U.S. District Court for the District of Delaware...